Statistics
Publications
170
Citations
26.9K
H-Index
63
Active since
1960
Paul Nathan is an author at Mount Vernon Cancer Centre specializing in oncology, medicine, and pharmacology.
Publications per year
1960–2025
170
170
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text
Medicine, Oncology, Pharmacology +17
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Robert J. Motzer, Thomas E. Hutson, David Cella et al. · New England Journal of Medicine · 2013 · 1.9K citations · Full text
Medicine, Oncology, Pharmacology +13
Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
Georgina V. Long, Daniil Stroyakovskiy, Helen Gogas et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text
Medicine, Oncology, Pharmacotherapy +14
1–5 of 170